A citation-based method for searching scientific literature

Marty Mrazik, Scott Millis, Daniel L Drane. Arch Clin Neuropsychol 2010
Times Cited: 42







List of co-cited articles
156 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L Cummings, Howard Chertkow. J Am Geriatr Soc 2005
23





Oral trail making task as a discriminative tool for different levels of cognitive impairment and normal aging.
G Bastug, E T Ozel-Kizil, A Sakarya, O Altintas, S Kirici, U Altunoz. Arch Clin Neuropsychol 2013
14
42

Neuropsychological Test Administration by Videoconference: A Systematic Review and Meta-Analysis.
Timothy W Brearly, Robert D Shura, Sarah L Martindale, Rory A Lazowski, David D Luxton, Brian V Shenal, Jared A Rowland. Neuropsychol Rev 2017
143
14

Clinical pharmacology and toxicology of cocaine.
N L Benowitz. Pharmacol Toxicol 1993
148
11


Validity of Teleneuropsychological Assessment in Older Patients with Cognitive Disorders.
Hannah E Wadsworth, Kaltra Dhima, Kyle B Womack, John Hart, Myron F Weiner, Linda S Hynan, C Munro Cullum. Arch Clin Neuropsychol 2018
57
11

Teleneuropsychology: evidence for video teleconference-based neuropsychological assessment.
C Munro Cullum, L S Hynan, M Grosch, M Parikh, M F Weiner. J Int Neuropsychol Soc 2014
122
11

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
A Richard Green, Annis O Mechan, J Martin Elliott, Esther O'Shea, M Isabel Colado. Pharmacol Rev 2003
821
9

Amphetamine toxicities: classical and emerging mechanisms.
Bryan K Yamamoto, Anna Moszczynska, Gary A Gudelsky. Ann N Y Acad Sci 2010
210
9

Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
Russell C Callaghan, James K Cunningham, Gautam Sajeev, Stephen J Kish. Mov Disord 2010
102
9

Evaluating cognition in an elderly cohort via telephone assessment.
Effie M Mitsis, Diane Jacobs, Xiaodong Luo, Howard Andrews, Karen Andrews, Mary Sano. Int J Geriatr Psychiatry 2010
20
20



Initial practice recommendations for teleneuropsychology.
Maria C Grosch, Michael C Gottlieb, C Munro Cullum. Clin Neuropsychol 2011
42
9

Video Teleconference Administration of the Repeatable Battery for the Assessment of Neuropsychological Status.
Jeanine M Galusha-Glasscock, Daniel K Horton, Myron F Weiner, C Munro Cullum. Arch Clin Neuropsychol 2016
48
9

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009
9

Validity of teleneuropsychology for older adults in response to COVID-19: A systematic and critical review.
David E Marra, Kristin M Hamlet, Russell M Bauer, Dawn Bowers. Clin Neuropsychol 2020
82
9

Amphetamine neurotoxicity: cause and consequence of oxidative stress.
Bryan K Yamamoto, Michael G Bankson. Crit Rev Neurobiol 2005
103
7


Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.
N D Volkow, L Chang, G J Wang, J S Fowler, Y S Ding, M Sedler, J Logan, D Franceschi, J Gatley, R Hitzemann,[...]. Am J Psychiatry 2001
615
7

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
N D Volkow, L Chang, G J Wang, J S Fowler, M Leonido-Yee, D Franceschi, M J Sedler, S J Gatley, R Hitzemann, Y S Ding,[...]. Am J Psychiatry 2001
688
7


Movement disorders.
F Cardoso, J Jankovic. Neurol Clin 1993
26
11

Mechanisms of neurotransmitter release by amphetamines: a review.
David Sulzer, Mark S Sonders, Nathan W Poulsen, Aurelio Galli. Prog Neurobiol 2005
789
7

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.
N D Volkow, L Chang, G J Wang, J S Fowler, D Franceschi, M Sedler, S J Gatley, E Miller, R Hitzemann, Y S Ding,[...]. J Neurosci 2001
428
7

A twin study of the neuropsychological consequences of stimulant abuse.
Rosemary Toomey, Michael J Lyons, Seth A Eisen, Hong Xian, Sunanta Chantarujikapong, Larry J Seidman, Stephen V Faraone, Ming T Tsuang. Arch Gen Psychiatry 2003
53
7

Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning.
Chad A Bousman, Mariana Cherner, Kristen T Emory, Daniel Barron, Patricia Grebenstein, J Hampton Atkinson, Robert K Heaton, Igor Grant. J Int Neuropsychol Soc 2010
5
60

Alcohol use and risk taking among regular ecstasy users.
Courtney Breen, Louisa Degenhardt, Stuart Kinner, Raimondo Bruno, Rebecca Jenkinson, Allison Matthews, Jaclyn Newman. Subst Use Misuse 2006
31
9


Demographic characteristics and normative observations for derived-trail making test indices.
Daniel L Drane, Robert L Yuspeh, Justin S Huthwaite, Lacey K Klingler. Neuropsychiatry Neuropsychol Behav Neurol 2002
127
7


An fMRI investigation of a novel analogue to the Trail-Making Test.
Sarah C Jacobson, Mathieu Blanchard, Colm C Connolly, Mary Cannon, Hugh Garavan. Brain Cogn 2011
59
7


Utility of TICS-M for the assessment of cognitive function in older adults.
Celeste A de Jager, Marc M Budge, Robert Clarke. Int J Geriatr Psychiatry 2003
291
7

Validation of a cognitive assessment battery administered over the telephone.
Stephen R Rapp, Claudine Legault, Mark A Espeland, Susan M Resnick, Patricia E Hogan, Laura H Coker, Maggie Dailey, Sally A Shumaker. J Am Geriatr Soc 2012
58
7

Construct validity in the Trail Making Test: what makes Part B harder?
E A Gaudino, M W Geisler, N K Squires. J Clin Exp Neuropsychol 1995
226
7

Screening for cognition and behaviour changes in ALS.
Sharon Abrahams, Judith Newton, Elaine Niven, Jennifer Foley, Thomas H Bak. Amyotroph Lateral Scler Frontotemporal Degener 2014
309
7


Oral adaptation of the Trail Making Test: A practical review.
Tobias Kaemmerer, Patrick Riordan. Appl Neuropsychol Adult 2016
9
33

InterOrganizational practice committee recommendations/guidance for teleneuropsychology (TeleNP) in response to the COVID-19 pandemic.
Robert M Bilder, Karen S Postal, Mark Barisa, Darrin M Aase, C Munro Cullum, Stephen R Gillaspy, Lana Harder, Geoffrey Kanter, Margaret Lanca, David M Lechuga,[...]. Clin Neuropsychol 2020
48
7

Consumer acceptability of brief videoconference-based neuropsychological assessment in older individuals with and without cognitive impairment.
Mili Parikh, Maria C Grosch, Lara L Graham, Linda S Hynan, Myron Weiner, James H Shore, C Munro Cullum. Clin Neuropsychol 2013
52
7

Dysbalance of cortical inhibition and excitation in abstinent cocaine-dependent patients.
Klevest Gjini, Ulf Ziemann, T Celeste Napier, Nash Boutros. J Psychiatr Res 2012
19
10


Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
A C Parrott, T Buchanan, A B Scholey, T Heffernan, J Ling, J Rodgers. Hum Psychopharmacol 2002
109
4

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
Andrew B Scholey, Andrew C Parrott, Tom Buchanan, Thomas M Heffernan, Jonathan Ling, Jacqui Rodgers. Addict Behav 2004
111
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.